HBV Discovery Services
A Platform Supporting HBV Drug Discovery
A broad assay platform for the discovery of agents for the treatment of chronic HBV infection.
Services for assay establishment and validation, compound screening and profiling, and support of preclinical studies and clinical trials.
- Drug screening using HBV producing cell lines
- HBV infectious assays
- Reporter assays
- Core protein expression
- Compound profiling
- Clinical virology
- Animal models
- Immunological assays supporting animal models
HBV Drug Discovery
Related Content
Targeted protein degradation (TPD) technology has become one of the most promising methods to remove specific disease-related proteins using cellular...
VIEW RESOURCEThe Son of Sevenless (SOS) protein is a guanine nucleotide exchange factor that acts as a key activator for KRAS...
VIEW RESOURCE